123 related articles for article (PubMed ID: 38775483)
1. Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study.
Ishigo T; Matsumoto K; Yoshida H; Tanaka H; Ibe Y; Fujii S; Fukudo M; Fujihara H; Yamaguchi F; Ebihara F; Maruyama T; Hamada Y; Samura M; Nagumoi F; Komatsu T; Tomizawa A; Takuma A; Chiba H; Nishi Y; Enoki Y; Taguchi K; Suzuki A
Microbiol Spectr; 2024 May; ():e0373923. PubMed ID: 38775483
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
[TBL] [Abstract][Full Text] [Related]
3. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
4. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
5. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
[TBL] [Abstract][Full Text] [Related]
6. Acute Kidney Injury Associated with Area under the Curve versus Trough Monitoring of Vancomycin in Obese Patients.
D'Amico H; Wallace KL; Burgess D; Burgess DS; Cotner S; Mynatt R; Li N; Stromberg A; VanHoose J
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0088621. PubMed ID: 34633843
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
Britt NS; Patel N; Horvat RT; Steed ME
Antimicrob Agents Chemother; 2016 May; 60(5):3070-5. PubMed ID: 26953202
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Vancomycin AUC
Hanai Y; Hashi H; Hanawa K; Endo A; Miyazaki T; Yamaguchi T; Harada S; Yokoo T; Uekusa S; Namiki T; Yokoyama Y; Asakawa D; Isoda R; Enoki Y; Taguchi K; Matsumoto K; Matsuo K
Pharm Res; 2024 Jun; ():. PubMed ID: 38886259
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.
Aljefri DM; Avedissian SN; Rhodes NJ; Postelnick MJ; Nguyen K; Scheetz MH
Clin Infect Dis; 2019 Nov; 69(11):1881-1887. PubMed ID: 30715208
[TBL] [Abstract][Full Text] [Related]
10. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
[TBL] [Abstract][Full Text] [Related]
11. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mathematical equation and trapezoidal approach for 24 h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting.
Chanapiwat P; Paiboonvong T; Rattanaumpawan P; Montakantikul P
Pharmacol Res Perspect; 2023 Feb; 11(1):e01046. PubMed ID: 36588162
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients with
Tochikura N; Matsumoto C; Iwabuchi S; Aso H; Fukushima S; Ootsuka S; Ooba N; Ishihara M; Nakajima H; Umemura H; Nakayama T
Eur J Hosp Pharm; 2023 Mar; ():. PubMed ID: 36868850
[TBL] [Abstract][Full Text] [Related]
14. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Drug Monitoring of Vancomycin in Adult Patients with Methicillin-Resistant
Marko R; Hajjar J; Nzeribe V; Pittman M; Deslandes V; Sant N; Cowan J; Kyermentang K; Ramsay T; Zelenitsky S; Kanji S
Can J Hosp Pharm; 2021; 74(4):334-343. PubMed ID: 34602621
[TBL] [Abstract][Full Text] [Related]
16. Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study.
Ishigo T; Fujii S; Ibe Y; Aigami T; Nakano K; Fukudo M; Yoshida H; Tanaka H; Ebihara F; Maruyama T; Hamada Y; Suzuki A; Fujihara H; Yamaguchi F; Samura M; Nagumo F; Komatsu T; Tomizawa A; Takuma A; Chiba H; Nishi Y; Enoki Y; Taguchi K; Matsumoto K
J Infect Chemother; 2024 Apr; 30(4):329-336. PubMed ID: 37925103
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
Abdelmessih E; Patel N; Vekaria J; Crovetto B; SanFilippo S; Adams C; Brunetti L
Pharmacotherapy; 2022 Sep; 42(9):741-753. PubMed ID: 35869689
[TBL] [Abstract][Full Text] [Related]
18. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
Ondrush NM; Ademovic R; Seabury RW; Darko W; Miller CD; Mogle BT
J Clin Pharm Ther; 2022 Dec; 47(12):2223-2229. PubMed ID: 36351763
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an AUC
Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
